Emerald Mutual Fund Advisers Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-79,460	Closed	-$7.31M	–	229
2013 Q3	$7.31M	Buy	79,460 +530	+0.7%	+$42.8K	1.01%	31
2013 Q2	$5.42M	Buy	+78,930	New	+$4.82M	0.92%	38

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's JAZZ Position: Q4 2013 in Review

Emerald Mutual Fund Advisers Trust sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2013, closing a stake of 79,460 shares — an estimated $7.31M sold.

Emerald Mutual Fund Advisers Trust first reported a position in JAZZ in Q2 2013 and held it in 2 quarters. The position peaked at $7.31M in Q3 2013. 280 funds tracked by Wall St. Rank hold JAZZ as of Q4 2013.

Emerald Mutual Fund Advisers Trust reported no remaining Jazz Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 79,460 Jazz Pharmaceuticals shares in Q4 2013, an estimated $7.31M.
Emerald Mutual Fund Advisers Trust first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 2 quarters.
Emerald Mutual Fund Advisers Trust's Jazz Pharmaceuticals position peaked at $7.31M in Q3 2013.
280 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2013.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2013, filed 30 Jan 2014.